Oral Squamous Cell Carcinoma Oscc clinical trials

Explore recruiting oral squamous cell carcinoma oscc clinical trials.

Recruiting oral squamous cell carcinoma oscc studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oral Squamous Cell Carcinoma Oscc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NOCANO: Nivolumab as neoadjuvant immunotherapy for patients with Oral CANcer and identification of response-predictive biomarkers in tumour draining lymph NOdes

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Oral Squamous Cell Carcinoma Oscc trials by city

Oral Squamous Cell Carcinoma Oscc clinical trials

Recruiting oral squamous cell carcinoma oscc studies right now

Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients

Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative

Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

Also recruiting in Europe

NOCANO: Nivolumab as neoadjuvant immunotherapy for patients with Oral CANcer and identification of response-predictive biomarkers in tumour draining lymph NOdes

Oral Squamous Cell Carcinoma Oscc trials by city

Other conditions